Comparison of 68Ga-DOTA-JR11 PET/CT with (dosimetric) 177Lu-DOTA-JR11 SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy

Krebs, Shiri; O'Donoghue, J; Biegel, E; Beattie, BJ; Reidy, D; Bodei, L; Weber, WA; Pandit-Taskar, N

Comparison of ⁶⁸Ga-DOTA-JR11 PET/CT with (dosimetric) ¹⁷⁷Lu-DOTA-JR11 SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy

journal contribution

posted on 2025-04-09, 04:30 authored by Shiri KrebsShiri Krebs, J O'Donoghue, E Biegel, BJ Beattie, D Reidy, L Bodei, WA Weber, N Pandit-Taskar

Comparison of ⁶⁸Ga-DOTA-JR11 PET/CT with (dosimetric) ¹⁷⁷Lu-DOTA-JR11 SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy

History

Journal

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Volume

45

Pagination

S63-S64

Location

GERMANY, Dusseldorf

ISSN

1619-7070

eISSN

1619-7089

Language

English

Publication classification

E3.1 Extract of paper

Publisher

SPRINGER

Usage metrics

Keywords

Science & Technology Life Sciences & Biomedicine Radiology, Nuclear Medicine & Medical Imaging

Comparison of ⁶⁸Ga-DOTA-JR11 PET/CT with (dosimetric) ¹⁷⁷Lu-DOTA-JR11 SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy

History

Journal

Volume

Pagination

Location

ISSN

eISSN

Language

Publication classification

Publisher

Usage metrics

Categories

Keywords

Licence

Exports